Soligenix appoints Kevin Horgan chief medical officer
This article was originally published in Scrip
Executive Summary
Soligenix has named Dr Kevin Horgan senior vice-president and chief medical officer. He is a gastroenterologist with a research background in cellular immunology, and has more than 25 years' experience in both academia and industry, including Merck, Centocor and GE Healthcare. Soligenix is a biopharmaceutical company developing products to treat life-threatening side-effects of cancer treatments and gastrointestinal diseases, and vaccines for certain bioterrorism agents.